SECsense Logo

Silexion Therapeutics Corp 8-K Filing: Key Insights on Shares & Warrants

$SLXN
Form 8-K
Filed on: 2024-12-17
Source
Silexion Therapeutics Corp 8-K Filing: Key Insights on Shares & Warrants

Based on the provided XML section of the financial report, here are the key insights and information extracted:

  1. Entity Identification:
  • Name: Silexion Therapeutics Corp
  • CIK: 0002022416
  • SEC Filing Type: 8-K
  • Date of Filing: December 17, 2024
  • Address: 12 Abba Hillel Road, Ramat-Gan, IL 5250606
  • Phone: 8-6286005
  1. Stock Information:
  • Ordinary Shares:
    • Par Value: $0.0009 per share
    • Ticker Symbol: SLXN
  • Warrants:
    • Warrants Exercisable for Ordinary Shares: Yes
    • Exercise Price: $103.50 per share
    • Ticker Symbol for Warrants: SLXNW
  1. Filing Context:
  • The filing context indicates specific classes of stock being reported, including:
    • Warrants Exercisable for Ordinary Shares at an exercise price of $115.00 per share.
    • Ordinary Shares with a par value of $0.0001 per share.
  1. Report Structure:
  • The information is structured in an XML format compliant with XBRL standards, indicating a formal and regulated reporting process.
  1. Analysis:
  • The report pertains to a single day (December 17, 2024), which suggests that this may be a specific event or a snapshot of financial standing rather than a comprehensive quarterly or annual report.
  • The presence of warrants suggests potential future dilution of shares, which could impact existing shareholders, depending on the exercise of these warrants.

Overall, this section indicates that Silexion Therapeutics Corp is actively engaged in the issuance of both ordinary shares and warrants, with specified pricing and structure as part of its financial instruments. Further analysis would require additional context around the financial performance or strategic implications of these instruments.